Definitive Healthcare Corp. (NASDAQ:DH) Sees Large Increase in Short Interest

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 3,710,000 shares, an increase of 23.3% from the March 15th total of 3,010,000 shares. Approximately 9.1% of the shares of the stock are sold short. Based on an average daily volume of 1,100,000 shares, the days-to-cover ratio is presently 3.4 days.

Institutional Investors Weigh In On Definitive Healthcare

Large investors have recently made changes to their positions in the business. Irenic Capital Management LP lifted its position in Definitive Healthcare by 9.2% during the fourth quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock valued at $28,783,000 after buying an additional 590,009 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Definitive Healthcare by 1.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,863,912 shares of the company's stock valued at $7,661,000 after purchasing an additional 23,410 shares during the last quarter. State Street Corp boosted its holdings in Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company's stock worth $6,257,000 after purchasing an additional 317,952 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Definitive Healthcare by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company's stock valued at $5,231,000 after buying an additional 39,938 shares during the period. Finally, 272 Capital LP grew its holdings in shares of Definitive Healthcare by 74.8% in the third quarter. 272 Capital LP now owns 1,114,080 shares of the company's stock worth $4,980,000 after acquiring an additional 476,766 shares during the period. 98.67% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have issued reports on DH shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Barclays reduced their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a research note on Monday, March 3rd. Finally, The Goldman Sachs Group cut their price target on shares of Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 4th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $5.35.

Definitive Healthcare Stock Performance

Shares of NASDAQ DH traded up $0.04 during midday trading on Thursday, hitting $2.65. The company's stock had a trading volume of 42,754 shares, compared to its average volume of 849,584. The firm has a market capitalization of $298.65 million, a price-to-earnings ratio of -0.85, a P/E/G ratio of 4.06 and a beta of 1.48. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average price of $3.13 and a 200 day moving average price of $4.01. Definitive Healthcare has a one year low of $2.15 and a one year high of $7.47.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). The company had revenue of $62.29 million for the quarter, compared to analysts' expectations of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. On average, research analysts forecast that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.